Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series
详细信息 查看全文
- 作者：Yoto Oh (1) (2)
Yoshiaki Wakabayashi (1)
Yoshiro Kurosa (2)
Masafumi Ishizuki (3)
Atsushi Okawa (1) - 刊名：Journal of Orthopaedic Science
- 出版年：2014
- 出版时间：July 2014
- 年：2014
- 卷：19
- 期：4
- 页码：579-586
- 全文大小：2,460 KB
- 参考文献：1. Pentecost RL, Murray RA, Brindley HH. Fatigue, insufficiency, and pathologic fractures. JAMA. 1964;187:1001-. CrossRef
2. Devas M. Stress fractures of the femur. Stress fractures. Edinburgh: Churchill Livingstone; 1975. p. 107-9.
3. Niimi R, Hasegawa M, Sudo A, Uchida A. Unilateral stress fracture of the femoral shaft combined with contralateral insufficiency fracture of the femoral shaft after bilateral total knee arthroplasty. J Orthop Sci. 2008;13:572-. CrossRef
4. Lim HC, Bae JH, Yi JW, Park JH. Bilateral stress fracture of the femoral shaft after total knee arthroplasty. Knee. 2011;18:354-. CrossRef
5. Oh Y, Wakabayashi Y, Okawa A, Ishizuki M, Kurosa Y. Diagnosis and treatment for stress fractures of bilateral femoral shafts in the elderly. Bessatsu Seikeigeka (Orthopaedic Surgery). 2012;61:174- (in Japanese).
6. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294-01. CrossRef
7. Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89:349-3. CrossRef
8. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39:224-1. CrossRef
9. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008;358:1304-. CrossRef
10. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346-0. CrossRef
11. Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures inpatients on long-term alendronate therapy. J Bone Joint Surg Am. 2009;91:2556-1. CrossRef
12. Somford MP, Draijer FW, Thomassen BJ, Chavassieux PM, Boivin G, Papapoulos SE. Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility. J Bone Miner Res. 2009;24:1736-0. CrossRef
13. Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2009;24:1095-02. CrossRef
14. Armamento-Villareal R, Napoli N, Diemer K, Watkins M, Civitelli R, Teitelbaum S, Novack D. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series. Calcif Tissue Int. 2009;85:37-4. CrossRef
15. De Das S, Setiobudi T, Shen L, De Das S. A rational approach to management of alendronate-related subtrochanteric fractures. J Bone Joint Surg Br. 2010;92:679-6. CrossRef
16. Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, Mckiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M, American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25:2267-4. CrossRef
17. Ng YH, Gino PD, Lingaraj K, De Das S. Femoral shaft fractures in the elderly—role of prior bisphosphonate therapy. Injury. 2011;42:702-. CrossRef
18. Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, Fracture Intervention Trial Steering Committees, HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362:1761-1. CrossRef
19. Schilcher J, Micha?lsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364:1728-7. CrossRef
20. Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011;305:783-. CrossRef
21. Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E. Incidence and demograohy of femur fractures with and without atypical fractures. J Bone Miner Res. 2012;27:977-6. CrossRef
22. Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM. Incidence of atypical no traumatic diaphyseal fractures of the femur. J Bone Miner Res. 2012;27:2544-0. CrossRef
23. Beaudouin-Bazire C, Dalmas N, Bourgeois J, Babinet A, Anract P, Chantelot C, Farizon F, Chopkin F, Briot K, Roux C, Cortet B, Thomas T. Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis. Joint Bone Spine. 2013;80:201-. CrossRef
24. Schneider JP, Hinshaw WB, Su C, Solow P. Atypical femur fractures: 81 individual personal histories. J Clin Endocrinol Metab. 2012;97:4324-. CrossRef
25. Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29:1-4. CrossRef
26. Egol KA, Chang EY, Cvitkovic J, Kummer FJ, Koval KJ. Mismatch of current intramedullary nails with the anterior bow of the femur. J Orthop Trauma. 2004;18:410-. CrossRef
27. Ehmke LW, Polzin BM, Madey SM, Bottlang M. Femoral nailing through the trochanter: the reamer pathway indicates a helical nail shape. J Orthop Trauma. 2006;20:668-4.
28. Maehara T, Shinohara K, Yamashita K, Bun H, Kaneda D, Ikuma H. The morphology of the femur in elderly Japanese female: analysis using 3D-CT. Kossetsu (Fracture). 2012;34:451- (in Japanese).
29. Nanka O, Havranek P. Physiological bowing of the human femur and its clinical significance. Acta Chir Orthop Traumatol Cech. 2000;67:225- (in Czech).
30. Kiura Y. A roentgenographical study on osteoarthritis of the knee by the evaluation of the alignment of the lower extremities. J Wakayama Med Soc. 1984;35:343-5 (in Japanese). - 作者单位：Yoto Oh (1) (2)
Yoshiaki Wakabayashi (1)
Yoshiro Kurosa (2)
Masafumi Ishizuki (3)
Atsushi Okawa (1)
1. Department of Orthopaedic and Spinal Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
2. Department of Orthopaedic Surgery, Saku Central Hospital, Saku, Japan
3. Department of Orthopaedic Surgery, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan - ISSN：1436-2023
文摘
Background We have studied stress fractures of the bowed femoral shaft (SBFs) among elderly Japanese for over a decade. On the other hand, severely suppressed bone turnover (SSBT) after long-term bisphosphonates (BPs) use has been considered to be one of the causes of low-energy diaphyseal femoral fractures, often called atypical femoral fractures (AFFs). Some studies have shown that BPs use for more than 5?years is associated with an increased risk of AFFs. Here, we present a report of our SBF case series experienced in the past 15?years in order to examine whether bowing deformity should be considered among the causes of AFFs. Methods Subjects were 13 Japanese female patients with low-energy femoral shaft fractures. Mean age at injury was 77.0?years (range 67-8?years). All patients met the criteria of the AFFs-case definition. The first author treated 11 of the 13 patients over 8?years (2005-012) based on the concept of SBFs. Regarding the regional characteristics of these patients, 10 were treated at 2 rural hospitals, and 3 were treated at 3 urban hospitals. Retrospectively, we assessed fracture type and location, existence of fracture on the contralateral side, bowing deformity, and duration of BPs use. Results All 13 cases were AO/OTA type 32-A. Incomplete or previous fracture on the contralateral side was noted in 10 cases. Obvious bowing deformity of the femoral shaft was noted in 12 cases. BPs were taken in 7 cases, only 3 of which involved BPs use for more than 5?years. Conclusions We experienced 12 cases of low-energy femoral shaft fractures associated with bowing deformity. Six cases were not treated with BPs at all. Stress fractures associated with a femoral shaft bowing deformity do actually exist and should be recognized as another cause of AFFs.